Phase III
A 20-Week Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial of EPX-100 (Clemizole Hydrochloride) as Adjunctive Therapy in Children and Adult Participants with Dravet Syndrome (ARGUS Trial)
- Study IRB#:2000040323
- Last Updated:10/07/2026
- Age2 years and older
- GenderBoth
Contact Us
For more information about this study, including how to volunteer, contact:
Aline Herlopian
Help Us Discover!
You can help our team find trials you might be eligible for by creating a volunteer profile in MyChart. To get started, create a volunteer profile, or contact helpusdiscover@yale.edu, or call 877-978-8343 for more information.
